Epidemiology of Tuberculosis in Hong Kong

Slides:



Advertisements
Similar presentations
WELCOME HEALTH PROFILE BANGLADESH. MINISTRY OF HEALTH & FAMILY WELFARE (MOHFW)-BANGLADESH MOHFW is responsible to ensure basic health care to the people.
Advertisements

Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Revised National Tuberculosis Control Programme (RNTCP)
GRENADA PRESENTATION Presenter: Tessa Stroude. GEOGRAPHICAL LOCATION.
Country Statistics PAKISTAN: Epidemiological Transition Dr. Babar T. Shaikh The Aga Khan University, Karachi, Pakistan.
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
Potential Cost-Effectiveness of a Tuberculosis Vaccine: Implications for Clinical Trials Jared Ditkowsky Kevin Schwartzman MD, MPH Montreal Chest Institute,
Community Medicine Community Medicine A system of delivery of comprehensive health care to the people by a health team in order to improve the health of.
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
Progress of the Singapore TB Elimination Programme (STEP)
ACTION PLAN FOR TUBERCULOSIS CONTROL PAPUA NEW GUINEA DR. JOSEPH BANA-KOIRI.
“Progress and Challenges in Achieving the Millennium Development Goals” by H.M.Gunasekera Director General, National Planning Ministry of Finance and Planning.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
HIV and AIDS Data Hub for Asia-Pacific 1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Malaysia.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides Japan.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
HEALTH SITUATION IN MONGOLIA
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
HIV and AIDS Data Hub for Asia-Pacific 1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
HIV and AIDS Data Hub for Asia-Pacific 1 HIV and AIDS Data Hub for Asia-Pacific Review in slides Hong Kong, SAR.
Tajikistan: Health Profile By: Moulika Baireddy and Supercourse developers.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Reducing Deaths from TB & Tobacco Together
Millennium Development Goals (MDGs)
TB- HIV Collaborative activities in Romania- may 2006 status
Bhutan Last updated: September 2016.
7TH – 12TH MARCH 2011 LAUSANNE , SWITZERLAND
Non-Communicable Diseases Risk Factors Survey in Georgia
Mongolia Last updated: April 2016.
Non Communicable Diseases State of Qatar
Pakistan Last updated: July 2015.
Daffodil International University (DIU), Dhaka Bangladesh
PROGRESS IN GLOBAL TB CONTROL
Diabetes in Suriname II PAHO-DOTA Workshop on Quality of Diabetes Care
The Role of Health Institute Kingdom of Bahrain
Bronx Community Health Dashboard: Drug Abuse and Opioids Created: 5/18/2017 Last Updated: 10/23/2017 See last slide for more information.
Table 7.3: Age-adjusted Death Rates, Selected Causes, by Race, 2014
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Background 1  § About 1/3 of world population infected with Tuberculosis (TB) § 25% of all avoidable deaths in developing countries due to TB.
NCD – Kingdom of Saudi Arabia
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
TB epidemiological situation in Kyrgyzstan
WS on Surveillance & Epidemiology
Papua New Guinea.
DOTS EXPANSION AND BEYOND DOTS World Health Organization
From TB control to integrated respiratory disease control
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
National Tuberculosis Control Program Department of Health Philippines Dr. Vivian S. Lofranco Medical Specialist IV.
Cheng shiming National TB Center in China May,3, 2004
Review in slides Hong Kong, SAR
Hong Kong, SAR.
Papua New Guinea.
Surveillance of Tuberculosis
National Tuberculosis Control Program in Vietnam
TB epidemiology in Bulgaria
PROGRESS IN GLOBAL TB CONTROL
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Epidemiological Terms
TB notification in Hong Kong
Issues on the current information system
Country presentation Dr.Vija Riekstina National TB registry
Bhutan Last updated: July 2018.
Data Hub for Asia-Pacific
Belize Presentation Dr. Ines Mendez-Moguel
Presentation transcript:

Epidemiology of Tuberculosis in Hong Kong Dr Chan Chi-kuen, Alan Senior Medical Officer TB & Chest Service, Department of Health Hong Kong Special Administrative Region

Location and population of Hong Kong Situated in south of China land area 1,098 square kilometers population of 6,782,100 at mid-2000 population density of ~6,500 /sq.Km proportion aged 65 and over: 8% in 1989 and 10.9% in 2000

Location and population of Hong Kong Highly mobile population people from 170 countries visit Hong Kong visa free passenger traffic: 115.5 million in 1998 and 129 million in 1999 increase mainly due to heavy cross-boundary traffic on land after return of Hong Kong’s sovereignty to China in 1997

General Background (1) (Year 2000) Mid-year Male Female GDP per capita : US$24,403* Annual population growth rate : 0.9% Life expectancy at birth - Male : 77.0 years - Female : 82.2 years Infant mortality rate : 2.9 (per 1 000 registered live births) % population with access to safe water : 99.9%† Literacy rate : 92.4% (percentage of population aged 15 and over who have attained primary education or above) Notes : * Figure is subject to revision later on. † Figure for year 1999 80+ 75-79 70-74 65-69 60-64 55-59 50-54 45-49 40-44 35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-4 Population (in thousands)

Population pyramids 2001 (mid-year) 1971 (mid-year) Male Female Male 85+ 80-84 75-79 70-74 65-69 60-64 55-59 50-54 45-49 40-44 35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-4 85+ 80-84 75-79 70-74 65-69 60-64 55-59 50-54 45-49 40-44 35-39 30-34 25-29 20-24 15-19 10-14 5-9 0-4 Population (in thousands) Population (in thousands)

General health services (1) Health infrastructure (As at end 2000) Notes : * The figure refers to Hospital Authority hospitals. † The figure covers the institutions licensed under the Hospitals, Nursing Homes and Maternity Homes Registration Ordinance (Cap. 165). ‡ The figure covers the clinics and maternity homes under the Department of Health and the clinics in the correctional institutions. § The figure covers the GOP clinics with A&E service and maternity homes of the Department of Health and the hospitals in the correctional institutions.

Latest TB indicators (2001) No of new cases (all types) and rate 6,556 (97.5/100,000) No new smear positive and rate 1,857 (27.6/100,000) % smear positive out of total new cases 28.3% % retreatment cases out of total new plus retreatment 9.7% % population with access to DOTS Near 100% DOTS cure rate (new bact. positive cases) 67.9% DOTS success rate (new bact. positive cases) 76.8% DOTS case detection rates 51%(WHO estimation)

No. of TB cases (2002)

TB rate per 100,000 (2002)

General Background (2) 5 Leading Causes of Hospitalisation (1999) 5 Leading Cause of Mortality (1999) Male & Female combined Male Female Heart disease and stroke Malignant neoplasm Malignant neoplasms Heart diseases, including hypertensive heart disease Unintentional injury Cerebrovascular disease Direct obstetric causes Pneumonia, all forms COPD and asthma Injury and poisoning Note: hospitalization figures include data from private and public hospitals Source: Department of Health, Annual Report 1999/2000

Treatment outcomes (percents) 1998 1999 2000 2001 2002 Cured 71.8% 70.4% 64.8% 67.0% - Completed 7.8% 7.3% 8.0% 8.7% Defaulted 4.6% 4.7% 6.1% 4.5% Failed 6.9% 7.9% 9.2% 8.1% Died 4.2% 5.5% 3.9% 5.4% Transferred out 2.8% Non evaluated 3.5%

HIV Prevalence (2002) No. of samples/ type of sample No. of samples tested anti-HIV + Prevalence (%) Blood donors 42,292 (blood) 1 0.002 Clients attending Social Hygiene Services 53,363 (blood) 41 0.077 Drug users attending methadone clinic (UAS) 4,037 (urine) 10 0.248 Drug users attending methadone clinic (voluntary blood testing) 318 (blood)

HIV Prevalence (2002) No. of samples/ type of sample No. of samples tested anti-HIV + Prevalence (%) Patients attending chest clinic (UAS) 866 (urine) 8 0.924 Patients attending chest clinics (voluntary blood testing) 3,186 (blood) 7 0.22 Antenatal women 41,932 (blood) 0.02%

UAS for HIV in TB & Chest Service (1990 to 2001) Period Category Sample No. Tested (No. +ve) 1.12.90 - 31.1.91 Outpatient Blood 1548 5.6.91 - 5.8.91 Inpatient 485 1.4.92 – 30.6.92 1469 (2) 1.4.92 – 30.6.93 1173 Sep 95 – Nov 95 Urine 895 Sep 96 – Dec 96 998 (4) Oct 97 – Jan 98 1003 Oct 98 – Jan 99 833 Sep 99 – Dec 99 1166 (8) Sep 00 – Dec 00 1018 (5) Oct 01 – Dec 01 1071

Information system National Reference Lab (since 1998) Data flow National Reference Lab (since 1998) PATIENT WITH TUBERCULOSIS Data for cross-matching Department of Health General out- patient clinics Hospital Authority Accident and Emergency Departments Department of Health Chest Clinic (Case notification) & (Follow up) PRIMARY LEVEL Private Practitioner Death certificates (since 1999) Please use the sample flowchart provided, or modify it in accordance to your information system, to explain the process of TB surveillance as follows: What data are collected Where are data collected: at what level and by whom Where do data go—which levels Where are data compiled for reporting Who reports and to where How is treatment evaluated, e.g. cohort analysis Hospital Authority Chest Hospitals Hospital Authority Specialist Out-patient Clinics Private Hospitals SECONDARY LEVEL Hospital Authority General

Sample of TB Notification Form (used since 1995)

Using information from death certificate The percentages of notified cases traced back by using TB lab. data and death cert. information Year Using TB lab.data Using information from death certificate 1998 13.06% - 1999 10.34% 12.68% 2000 7.92% 12.96% 2001 5.14% 7.32% 2002 4.84% 6.31% 2003 4.47% 5.67% Overall 7.55% 8.85%

Sample of TB Denotification Form (Since 1999)

No. of notifications and de-notifications by year No. of de-notifications 1998 7,673 38 1999 7,512 77 2000 7,578 87 2001 7,262 228 2002 6,602 274

CONTROL OF TUBERCULOSIS IN HONG KONG Strategies - Case finding: passive vs active - Effective chemotherapy: DOTS - Treatment of latent TB infection (preventive treatment or chemoprophylaxis) - BCG vaccination - (Health education) 23